Loading...

Eisai Co., Ltd.

ESALYPNK
HealthcareDrug Manufacturers - Specialty & Generic
$61.51
$-1.32(-2.11%)

Eisai Co., Ltd. ESALY Peers

See (ESALY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ESALY$61.51-2.11%17.6B20.54$3.00N/A
MKGAF$133.94+0.89%58.2B18.20$7.36+1.62%
MKKGY$26.44+0.48%57.8B17.99$1.47+2.17%
HLNCF$5.63-0.18%50.8B26.81$0.21+1.93%
TKPHF$27.60-1.53%43.4B58.72$0.47+4.82%
IPSEY$30.32+1.25%40.1B24.85$1.22N/A
SDZNY$53.51+0.07%23B-2675.25-$0.02+1.27%
TEVJF$17.80N/A20.4B-15.48-$1.15N/A
SGIOY$8.40+0.12%14.3B12.00$0.70+0.84%
SGIOF$16.45+8.22%14B11.67$1.41+2.74%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ESALY vs MKGAF Comparison

ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ESALY stands at 17.6B. In comparison, MKGAF has a market cap of 58.2B. Regarding current trading prices, ESALY is priced at $61.51, while MKGAF trades at $133.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ESALY currently has a P/E ratio of 20.54, whereas MKGAF's P/E ratio is 18.20. In terms of profitability, ESALY's ROE is +0.06%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ESALY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.

Stock Price Comparison

Loading...

Frequently Asked Questions